Vitamin D supplementation did not consistently reduce relapse rates in adults with multiple sclerosis (MS), although it may reduce the number of MS lesions seen on MRI scans, according to a systematic review of published studies. Several trials found reductions in new or active lesions even when vitamin D did not significantly reduce relapse frequency.
Vitamin D supplementation did not consistently reduce relapse rates in adults with multiple sclerosis (MS), although it may reduce the number of MS lesions seen on MRI scans, according to a systematic...
Several trials found reductions in new or active lesions even when vitamin D did not significantly reduce relapse frequency.
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Vitamin D supplementation did not consistently reduce relapse rates in adults with multiple sclerosis (MS), although it may reduce the number of MS lesions seen on MRI scans, according to a systematic review of published studies. Several trials found reductions in new or active lesions even when vitamin D did not significantly reduce relapse frequency.
Open the app view to save this story, compare related coverage, and continue from the same source.